Related references
Note: Only part of the references are listed.Incidence and progression of diabetic retinopathy: a systematic review
Charumathi Sabanayagam et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
Catharina Busch et al.
ACTA DIABETOLOGICA (2018)
Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema
Ali Demircan et al.
JOURNAL OF OPHTHALMOLOGY (2018)
Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment A Secondary Analysis of a Randomized Clinical Trial
Neil M. Bressler et al.
JAMA OPHTHALMOLOGY (2018)
Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
Maria Waizel et al.
BMC OPHTHALMOLOGY (2017)
Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema
Ehsan Rahimy et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)
Treatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapy
Rehan M. Hussain et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2016)
Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment
Susan B. Bressler et al.
JAMA OPHTHALMOLOGY (2016)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
John A. Wells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Intravitreal Aflibercept for Diabetic Macular Edema 100-Week Results From the VISTA and VIVID Studies
David M. Brown et al.
OPHTHALMOLOGY (2015)
Short-Term Outcomes of Aflibercept Therapy for Diabetic Macular Edema in Patients With Incomplete Response to Ranibizumab and/or Bevacizumab
Edward H. Wood et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2015)
Revision of visual impairment definitions in the International Statistical Classification of Diseases
Lalit Dandona et al.
BMC MEDICINE (2006)